BD (Becton, Dickinson and Company) has announced the launch of BD Micro-Fine+ 4 mm pen needle – claimed to be the world’s smallest pen needle.
This needle is proven to be as effective as longer needles for patients of all body types and proven to offer a less painful injection experience for the estimated 800,000 people in the UK with diabetes using injectable therapies. Jazz Panchoo, business director, UK and Ireland, BD Medical, Diabetes Care, comments: “We are confident that this tiny needle can have a big impact by easing diabetes patients’ transition to, and ongoing adherence to, injectable drug therapy regimens – a key element in helping to reduce the disease’s deadly, debilitating and costly complications.” Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety. The short length (4 mm) and thin gauge (32 G) of the BD Micro- Fine+ pen needle may help people with diabetes adhere to an insulin injection regimen and improve outcomes with its comfort and ease of use.
